QQ客服 官方微博 反馈留言

	Follistatin‐like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase‐dependent apoptosis and regulating Bcl‐2 family proteins
	Chunlei Li; Lei Dai; Junfeng Zhang; Yujing Zhang; Yi Lin; Lin Cheng; Hongwei Tian; Xin Zhang; Qingnan Wang; Qianmei Yang
刊名	Journal of Cellular and Molecular Medicine
	2018
卷号	Vol.22 No.12页码:6190-6201
关键词	apoptosis Bcl‐2 family proteins caspase FSTL5
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1870752
专题	四川大学
作者单位	1.Hongxin Deng, State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 2.State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China 3.Institute of Immunology and Molecular Medicine, Jining Medical University, Jining, Shandong, China 4.Department of Biochemistry, Faculty of Basic Medicine, Chongqing Three Gorges Medical College, Wanzhou, Chongqing, China
推荐引用方式 GB/T 7714	Chunlei Li,Lei Dai,Junfeng Zhang,et al. Follistatin‐like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase‐dependent apoptosis and regulating Bcl‐2 family proteins[J]. Journal of Cellular and Molecular Medicine,2018,Vol.22 No.12:6190-6201.
APA	Chunlei Li.,Lei Dai.,Junfeng Zhang.,Yujing Zhang.,Yi Lin.,...&Hongxin Deng.(2018).Follistatin‐like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase‐dependent apoptosis and regulating Bcl‐2 family proteins.Journal of Cellular and Molecular Medicine,Vol.22 No.12,6190-6201.
MLA	Chunlei Li,et al."Follistatin‐like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase‐dependent apoptosis and regulating Bcl‐2 family proteins".Journal of Cellular and Molecular Medicine Vol.22 No.12(2018):6190-6201.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。